Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational acyclovir therapy in herpetic eye disease.

M G Falcon

    The British Journal of Ophthalmology
    |February 1, 1987
    PubMed
    Summary

    Acyclovir is effective for treating herpes simplex eye disease. This review explores its pharmacology, pharmacokinetics, and clinical trial results to guide appropriate use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postgraduate ophthalmic training: how do we compare?

    Eye (London, England)·2011
    Same author

    An unusual corneal injury.

    The British journal of ophthalmology·1996
    Same author

    Ophthalmoscopic sign of early keratoconus.

    The British journal of ophthalmology·1994
    Same author

    The use of the same size host and donor trephine in penetrating keratoplasty for keratoconus.

    Eye (London, England)·1994
    Same author

    Decentration of the posterior chamber lens implant: the effect of optic size on the incidence of visual aberrations.

    Eye (London, England)·1990
    Same author

    Primary gelatinous drop-like keratopathy.

    The British journal of ophthalmology·1989

    Area of Science:

    • Ophthalmology
    • Virology
    • Pharmacology

    Background:

    • Herpes simplex virus (HSV) infections can cause various ocular manifestations.
    • Acyclovir has been a primary treatment option for HSV eye disease since its introduction.
    • Understanding its properties is crucial for effective clinical application.

    Purpose of the Study:

    • To review the rational indications for using acyclovir in treating herpes simplex eye disease.
    • To discuss the pharmacology and pharmacokinetics of acyclovir relevant to ocular infections.
    • To synthesize findings from clinical trials evaluating acyclovir's efficacy.

    Main Methods:

    • Literature review of pharmacological and pharmacokinetic data.
    • Analysis of results from clinical trials on acyclovir for ocular herpes simplex.
    • Synthesis of evidence to define appropriate clinical use.

    Main Results:

    • Acyclovir demonstrates significant efficacy in managing HSV ocular disease.
    • Pharmacological properties support its use in targeting viral replication.
    • Clinical trials confirm its therapeutic benefits and safety profile.

    Conclusions:

    • Acyclovir remains a cornerstone therapy for herpes simplex eye disease.
    • Evidence supports its use based on pharmacology, pharmacokinetics, and clinical outcomes.
    • Rational application of acyclovir ensures optimal patient management.

    Related Experiment Videos